US2021186882A1PendingUtilityA1

Freeze-dried alginic acid preparation

Assignee: MOCHIDA PHARM CO LTDPriority: Sep 7, 2015Filed: Mar 8, 2021Published: Jun 24, 2021
Est. expirySep 7, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61K 47/36A61P 19/08A61L 27/04A61K 31/734A61P 19/02A61L 27/20A61K 9/19A61L 27/54A61K 47/02A61L 2430/06A61P 19/00A61L 27/00C08B 37/0084
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides: a freeze-dried composition which comprises (a) a monovalent metal alginate and (b) a salt selected from a monovalent metal salt and an ammonium salt; and a method of producing a freeze-dried monovalent metal alginate composition which comprises the steps of freezing an aqueous solution formed by dissolving at least the component (a) and the component (b), performing first drying, and then performing second drying as desired to reduce a water content to 3% by mass or less. This is a freeze-dried monovalent metal alginate composition with suppressed viscosity decrease with the lapse of time.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A suppressant of viscosity decrease with the lapse of time for a freeze-dried monovalent metal alginate composition, comprising a salt selected from a monovalent metal salt and an ammonium salt, wherein the freeze-dried composition can be dissolved using an injection water and/or a physiological saline.

Join the waitlist — get patent alerts

Track US2021186882A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.